Schroder Investment Management Group
GCVRZ

Schroder Investment Management Group’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Schroder Investment Management Group’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,341
Closed -$1.55K – 1603
2014
Q3 		$1.55K Buy
+3,341
New +$1.62K ﹤0.01% 1424

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Schroder Investment Management Group's GCVRZ Position: Q4 2014 in Review

Schroder Investment Management Group sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2014, closing a stake of 3,341 shares — an estimated $1.55K sold.

Schroder Investment Management Group first reported a position in GCVRZ in Q3 2014 and held it in 1 quarter. The position peaked at $1.55K in Q3 2014. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2014.

  • Schroder Investment Management Group reported no remaining Sanofi Contingent Value Rights position as of Q4 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 3,341 Sanofi Contingent Value Rights shares in Q4 2014, an estimated $1.55K.
  • Schroder Investment Management Group first reported a position in Sanofi Contingent Value Rights in Q3 2014 and held it in 1 quarter.
  • Schroder Investment Management Group's Sanofi Contingent Value Rights position peaked at $1.55K in Q3 2014.
  • 118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2014.

Based on Schroder Investment Management Group's 13F filing for Q4 2014, filed 17 Feb 2015.